Safety and Efficacy of an Initial Regimen of Atazanavir + Ritonavir + the Abacavir/Lamivudine Fixed-Dose Combination Tablet for 36 weeks followed by Simplification to Atazanavir with ABC/3TC FTC or Maintenance of the Initial Regimen for an Additional 48

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/07 → 8/31/13

Funding

  • GlaxoSmithKline: $75,114.00